CS logo
small CS logo
Hospital Pablo Tobon Uribe

Medellin, Colombia
Hospital en Medellín

About Hospital Pablo Tobon Uribe


El Hospital Pablo Tobón Uribe es una institución hospitalaria de carácter privado, de origen testamentario, sin ánimo de lucro. Se encuentra ubicado en el barrio Córdoba, en la comuna Robledo de la Ciudad de Medellín, Colombia. Es una de las instituciones de salud más importantes de Colombia.​​
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Hospital Pablo Tobon Uribe


During the past decade, Hospital Pablo Tobon Uribe conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 49 clinical trials were completed, i.e. on average, 114% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 22 clinical trials were completed. i.e. 244.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
2003-04-01
Unknown status
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
2006-10-01
2011-04-01
Completed
349
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
2004-12-01
2010-06-01
Completed
67
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
2015-01-20
2020-08-14
Completed
645
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
2017-02-03
2019-12-26
Completed
326
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
2017-10-04
2025-04-23
Recruiting
336
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
2020-11-03
2021-05-31
Terminated
133

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Pablo Tobon Uribe" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Pfizer" with 12 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Hospital Pablo Tobón Uribe" with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 45 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Pablo Tobon Uribe" #1 collaborator was "Hospital Pablo Tobón Uribe" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "OCT Clinical Trials" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hospital Pablo Tobon Uribe


According to Clinical.Site data, the most researched conditions in "Hospital Pablo Tobon Uribe" are "Rheumatoid Arthritis" (8 trials), "Systemic Lupus Erythematosus" (6 trials), "Lupus Nephritis" (4 trials), "Multiple Myeloma" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Hospital Pablo Tobon Uribe" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Pablo Tobon Uribe


Most popular intervention types in "Hospital Pablo Tobon Uribe" are "Drug" (73 trials), "Other" (13 trials), "Biological" (11 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "Prednisone" (4 trials), "Docetaxel" (3 trials), "GDC-0853" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Pablo Tobon Uribe


The vast majority of trials in "Hospital Pablo Tobon Uribe" are 87 trials for "All" genders and 4 trials for "Male" genders.

Clinical Trials Status at Hospital Pablo Tobon Uribe


Currently, there are NaN active trials in "Hospital Pablo Tobon Uribe". undefined are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Hospital Pablo Tobon Uribe, undefined suspended trials, and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Pablo Tobon Uribe, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status